Literature DB >> 1379985

Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa.

E E Hughes1, L B Gilleland, H E Gilleland.   

Abstract

By using the published amino acid sequence for mature outer membrane protein F of Pseudomonas aeruginosa, a computer-assisted analysis was performed to identify sites with potential as surface-exposed, antigenic regions located throughout the length of the protein molecule. Synthetic peptides 13 to 15 amino acid residues in length were synthesized for 10 such regions. Mice were immunized with each of the 10 synthetic peptides conjugated to keyhole limpet hemocyanin. An enzyme-linked immunosorbent assay (ELISA) of the antisera was performed by using each of the synthetic peptides as the ELISA antigen to verify that immunoglobulin G (IgG) antibodies capable of reacting with the peptide used as immunogen were elicited by each peptide. Each of the antipeptide antisera was screened for the presence of IgG antibodies that could bind to the surface of intact cells of strains representing the seven heterologous Fisher-Devlin immunotypes of P. aeruginosa by use of an ELISA with whole cells of the various strains as the ELISA antigen. Three peptides elicited antibodies capable of reacting with whole cells of all seven immunotype strains. Peptide 10, corresponding to amino acid residues 305 to 318, elicited whole-cell-reactive antibodies at high titers. Peptide 9, corresponding to amino acid residues 261 to 274, elicited whole-cell-reactive antibodies at more intermediate titers. Peptide 7, corresponding to amino acid residues 219 to 232, elicited such antibodies only at low titers. The carboxy-terminal portion of the mature protein appears to be the immunodominant portion. In particular, peptides 10 (NATAEGRAINRRVE) and 9 (TDAYNQKLSERRAN) appear to have potential for use as immunogens in a synthetic vaccine for immunoprophylaxis against infections caused by P. aeruginosa. Antisera from mice immunized with either peptide 9 or 10 mediated opsonophagocytic uptake by human polymorphonuclear leukocytes of wild-type cells of P. aeruginosa but exhibited no opsonic activity against a protein F-deficient mutant of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379985      PMCID: PMC257350          DOI: 10.1128/iai.60.9.3497-3503.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Epitope mapping employing immobilized synthetic peptides. How specific is the reactivity of these peptides with antiserum raised against the parent protein?

Authors:  R Savoca; C Schwab; H R Bosshard
Journal:  J Immunol Methods       Date:  1991-08-09       Impact factor: 2.303

2.  UV-treated polystyrene microtitre plates for use in an ELISA to measure antibodies against synthetic peptides.

Authors:  F Boudet; J Thèze; M Zouali
Journal:  J Immunol Methods       Date:  1991-08-28       Impact factor: 2.303

3.  Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane.

Authors:  N Gotoh; H Wakebe; E Yoshihara; T Nakae; T Nishino
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

4.  Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection.

Authors:  M M Moon; L D Hazlett; R E Hancock; R S Berk; R Barrett
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-08       Impact factor: 4.799

Review 5.  Outer membrane proteins of Pseudomonas.

Authors:  R E Hancock; R Siehnel; N Martin
Journal:  Mol Microbiol       Date:  1990-07       Impact factor: 3.501

6.  Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man.

Authors:  R C Matthews; J P Burnie; S Tabaqchali
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

7.  Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.

Authors:  H E Gilleland; M G Parker; J M Matthews; R D Berg
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

8.  Evaluation of an immunofluorescent-antibody test for rapid identification of Pseudomonas aeruginosa in blood cultures.

Authors:  G W Counts; R W Schwartz; B K Ulness; D J Hamilton; M J Rosok; M D Cunningham; M R Tam; R P Darveau
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

9.  Outer membrane proteins of Pseudomonas aeruginosa serotype strains.

Authors:  L M Mutharia; T I Nicas; R E Hancock
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

10.  Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies.

Authors:  L M Mutharia; R E Hancock
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more
  24 in total

1.  Pseudomonas aeruginosa porin OprF exists in two different conformations.

Authors:  Etsuko Sugawara; Ekaterina M Nestorovich; Sergey M Bezrukov; Hiroshi Nikaido
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

Review 2.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

3.  Molecular cloning and sequence of the gene for outer membrane protein P5 of Haemophilus influenzae.

Authors:  R S Munson; S Grass; R West
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

4.  Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.

Authors:  B M Price; D R Galloway; N R Baker; L B Gilleland; J Staczek; H E Gilleland
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae.

Authors:  L A Novotny; J A Jurcisek; M E Pichichero; L O Bakaletz
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Outer Membrane Protein Heterogeneity within Pseudomonas fluorescens and P. putida and Use of an OprF Antibody as a Probe for rRNA Homology Group I Pseudomonads.

Authors:  L Kragelund; K Leopold; O Nybroe
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

7.  Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Authors:  B U von Specht; B Knapp; G Muth; M Bröker; K D Hungerer; K D Diehl; K Massarrat; A Seemann; H Domdey
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.

Authors:  Stefan Worgall; Anja Krause; JianPing Qiu; Ju Joh; Neil R Hackett; Ronald G Crystal
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  The C-terminal domain of Salmonella enterica serovar typhimurium OmpA is an immunodominant antigen in mice but appears to be only partially exposed on the bacterial cell surface.

Authors:  Shiva P Singh; Yvonne U Williams; Stephanie Miller; Hiroshi Nikaido
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa.

Authors:  H E Gilleland; E E Hughes; L B Gilleland; J M Matthews-Greer; J Staczek
Journal:  Curr Microbiol       Date:  1995-11       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.